肝素诱导的血小板减少检测。

IF 1.7 4区医学 Q3 MEDICAL LABORATORY TECHNOLOGY

Clinics in Laboratory Medicine Pub Date : 2024-05-30 DOI:10.1016/j.cll.2024.04.013

Daniel C. Dees DCLS, MLS(ASCP)

引用次数: 0

摘要

本文全面概述了肝素诱导的血小板减少症（HIT），重点介绍了实验室检测和自动化的优势。HIT 是一种由肝素暴露引起的危重病症，会导致血小板减少与血栓形成风险增加的矛盾结合。文章讨论了 HIT 的历史、临床表现、实验室诊断和管理策略。文章强调了跨学科合作对有效诊断和治疗的重要性，并强调了技术和靶向疗法的进步正在塑造未来的 HIT 管理方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Heparin Induced Thrombocytopenia Testing

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinics in Laboratory Medicine 医学-医学实验技术

CiteScore

3.30

自引率

5.90%

发文量

审稿时长

>12 weeks

期刊介绍： Clinics in Laboratory Medicine updates those practicing in the field of clinical pathology on the latest trends in clinical laboratory management, providing a sound basis for creating and working in a highly effective clinical laboratory. Published quarterly—in March, June, September, and December—each issue offers state-of-the-art reviews on a single topic in pathology, including quality control in lab testing, coagulation, clinical microbiology, toxicology testing, clinical cytogenetics, mass spectrometry, blood transfusion, and much more.